Lemaitre Vascular (LMAT) Interest & Investment Income (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Interest & Investment Income of $3.3 million for Q1 2026, up 14.5% year-over-year from $2.9 million in Q1 2025, and down 0.69% quarter-over-quarter from $3.3 million in Q4 2025.
Lemaitre Vascular (LMAT) Interest & Investment Income (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Interest & Investment Income for 17 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 14.5% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $13.5 million (up 97.27% YoY), while the FY2025 annual figure was $13.1 million, up 164.58% from the prior year.
- Interest & Investment Income slipped to $3.3 million in Q1 2026 per LMAT's latest filing, from $3.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.9 million in Q3 2025 and bottomed at $108000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.5 million across 5 years, with a median of $1.0 million in 2024.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 16600.0% — and 2026, when it gained 14.5%.
- Lemaitre Vascular's Interest & Investment Income stood at $447000.0 in 2022, then soared by 121.92% to $992000.0 in 2023, then surged by 62.3% to $1.6 million in 2024, then soared by 107.89% to $3.3 million in 2025, then slipped by 0.69% to $3.3 million in 2026.
- Business Quant data shows LMAT's Interest & Investment Income at $3.3 million in Q1 2026, $3.3 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 4.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 20.89 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -64.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -64.00 Mn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 992,000.00 |
| Sep 30, 2023 | 835,000.00 |
| Jun 30, 2023 | 682,000.00 |
| Mar 31, 2023 | 568,000.00 |
| Dec 31, 2022 | 447,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2022 | 108,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Sep 30, 2021 | 54,000.00 |